Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 January 2007, Vol. 109, No. 2, pp. 422-430.
Prepublished online as a Blood First Edition Paper on September 19, 2006; DOI 10.1182/blood-2006-04-001206.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-04-001206v1
109/2/422    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giannakopoulos, B.
Right arrow Articles by Krilis, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giannakopoulos, B.
Right arrow Articles by Krilis, S. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted April 20, 2006
Accepted August 25, 2006

Current concepts on the pathogenesis of the antiphospholipid syndrome

Bill Giannakopoulos, Freda Passam, Soheila Rahgozar, and Steven A. Krilis*

St. George Hospital, University of New South Wales, Sydney, Australia
Dept of Haematology, St. George Hospital, University of New South Wales, Sydney, Australia

* Corresponding author; email: s.krilis{at}unsw.edu.au.

The antiphospholipid syndrome (APS) is an important cause of acquired thrombophilia. It is characterised by the core clinical manifestations of thrombosis, either venous or arterial, and in women it can also be associated with recurrent fetal loss. The detection of persistently elevated levels of antiphospholipid antibodies (aPL Abs) is a requisite laboratory feature for the diagnosis to be made. The dominant antigenic targets in APS are beta 2-glycoprotein I ({beta}2-GPI) and prothrombin. There is an accumulating body of experimental evidence which suggests that specific subgroups of aPL Abs may directly contribute to disease pathogenesis. This review critically examines the experimental evidence underlying the various propositions made to explain how these antibodies may predispose to disease in humans. Furthermore, it also examines the evidence relating to the immunological mechanisms which may contribute to the breakage of peripheral tolerance in this disorder. Delineating the strengths and limitations of the experimental evidence accumulated thus far will hopefully stimulate further experimentation towards achieving the ultimate goal of precisely defining the dominant pathogenic mechanisms operational in APS. This may pave the way for the development of improved therapies.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
B. Giannakopoulos and S. A. Krilis
How I treat the antiphospholipid syndrome
Blood, September 3, 2009; 114(10): 2020 - 2030.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
C Pericleous, I Giles, and A Rahman
Are endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome?
Lupus, July 1, 2009; 18(8): 671 - 675.
[Abstract] [PDF]


Home page
LupusHome page
E. Peerschke, W Yin, D. Alpert, R. Roubey, J. Salmon, and B Ghebrehiwet
Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies
Lupus, May 1, 2009; 18(6): 530 - 538.
[Abstract] [PDF]


Home page
J. Immunol.Home page
I. Giles, C. Pericleous, X. Liu, J. Ehsanullah, L. Clarke, P. Brogan, M. Newton-West, R. Swerlick, A. Lambrianides, P. Chen, et al.
Thrombin Binding Predicts the Effects of Sequence Changes in a Human Monoclonal Antiphospholipid Antibody on Its In Vivo Biologic Actions
J. Immunol., April 15, 2009; 182(8): 4836 - 4843.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-H. Yang, D. Chien, M. Wu, J. FitzGerald, J. M. Grossman, B. H. Hahn, K.-K. Hwang, and P. P. Chen
Novel Autoantibodies against the Activated Coagulation Factor IX (FIXa) in the Antiphospholipid Syndrome That Interpose the FIXa Regulation by Antithrombin
J. Immunol., February 1, 2009; 182(3): 1674 - 1680.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Y. Chan, F. Andreotti, and R. C. Becker
Hypercoagulable States in Cardiovascular Disease
Circulation, November 25, 2008; 118(22): 2286 - 2297.
[Full Text] [PDF]


Home page
PediatricsHome page
T. Avcin, R. Cimaz, E. D. Silverman, R. Cervera, M. Gattorno, S. Garay, Y. Berkun, F. R. Sztajnbok, C. A. Silva, L. M. Campos, et al.
Pediatric Antiphospholipid Syndrome: Clinical and Immunologic Features of 121 Patients in an International Registry
Pediatrics, November 1, 2008; 122(5): e1100 - e1107.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
R Forastiero and M Martinuzzo
Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome
Lupus, October 1, 2008; 17(10): 872 - 877.
[Abstract] [PDF]


Home page
LupusHome page
I Giles, A Lambrianides, and A Rahman
Examining the non-linear relationship between monoclonal antiphospholipid antibody sequence, structure and function
Lupus, October 1, 2008; 17(10): 895 - 903.
[Abstract] [PDF]


Home page
LupusHome page
J. Rand, X. Wu, A. Quinn, and D. Taatjes
Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome
Lupus, October 1, 2008; 17(10): 922 - 930.
[Abstract] [PDF]


Home page
LupusHome page
E Cockrell, R. Espinola, and K. McCrae
Annexin A2: biology and relevance to the antiphospholipid syndrome
Lupus, October 1, 2008; 17(10): 944 - 952.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
R. M. Vanacore, A.-J. L. Ham, J.-P. Cartailler, M. Sundaramoorthy, P. Todd, V. Pedchenko, Y. Sado, D.-B. Borza, and B. G. Hudson
A Role for Collagen IV Cross-links in Conferring Immune Privilege to the Goodpasture Autoantigen: STRUCTURAL BASIS FOR THE CRYPTICITY OF B CELL EPITOPES
J. Biol. Chem., August 15, 2008; 283(33): 22737 - 22748.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
Y. Shoenfeld, P. L. Meroni, and R. Cervera
Antiphospholipid syndrome dilemmas still to be solved: 2008 status
Ann Rheum Dis, April 1, 2008; 67(4): 438 - 442.
[Full Text] [PDF]


Home page
haematolHome page
A. Membre, D. Wahl, V. Latger-Cannard, J.-P. Max, P. Lacolley, T. Lecompte, and V. Regnault
The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies
Haematologica, April 1, 2008; 93(4): 566 - 573.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. R. McCrae
Tissue factor needs a "complement"
Blood, October 1, 2007; 110(7): 2228 - 2228.
[Full Text] [PDF]


Home page
ASH Education BookHome page
J. H. Rand
The Antiphospholipid Syndrome
Hematology, January 1, 2007; 2007(1): 136 - 142.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020